StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SPREME-R.BK$1.53+0.00%
Fair $1.53+0.0%

SPREME-R.BK

SPREME-R.BK

Technology / Electronics & Computer DistributionThailand

$1.53

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $1.53Fund rank 27/100 · Data gapFallback financials|
SA 46/C
F-Score: 3/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 19%

FCF escenarios

weak_data · normalized FCF $-81.4M · quality 47.7/100

Data gap 27/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 18/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

46/100

C

Piotroski

3/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified.
Thesis & Journal · SPREME-R.BKLocal privado en este navegador · SPREME-R.BK
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.1B

P/E

7.0x

↓

EV/EBITDA

2.8x

↓

ROE

15.9%

↑

Gross Margin

19.3%

↓

Debt/Equity

0.02

↓
52-Week Range$2
$2$2

TradingView lightweight chart

SPREME-R.BK price, volumen y niveles de valoración

Último $1.530Periodo +0.0%
Fair value: $1.530

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

+15.0%

FCF CAGR

—

FCF margin

-5.2%

FCF / Net income

-0.51x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.56B · net income $161.0M · FCF $-81.4M

2022-FY → 2025-FY

Gross margin

19.3%-2.1% pts

Operating margin

13.0%+1.9% pts

Net margin

10.3%+0.7% pts

FCF margin

-5.2%-17.5% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$1.56B$1.56B$852.6M$1.26B$1.03B
Net Income$161.0M$161.0M$137.1M$156.6M$99.2M
EBITDA$322.3M$322.3M$249.9M$217.1M$139.8M
EPS0.220.220.200.210.13
Gross Margin19.3%19.3%30.5%23.1%21.4%
Operating Margin13.0%13.0%19.8%15.7%11.1%
Net Margin10.3%10.3%16.1%12.5%9.7%
Balance Sheet
Debt/Equity0.020.020.030.080.06
Current Ratio0.330.33———
Cash Flow
Free Cash Flow$-81.4M$-81.4M$-154.1M$167.4M$125.5M
Returns
ROE15.9%15.9%14.7%41.4%16.3%
Valuation
P/E6.956.95———
EV/EBITDA2.802.80———
P/B1.121.12———
Growth & Yield
Revenue Growth82.7%82.7%-32.1%22.5%—
EPS Growth10.0%10.0%-5.5%57.8%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

-14.9%

fácil

EPS terminal req.

$0.14

Spread vs growth

24.9%

5Y implied EPS CAGR

-5.7%

fácil

EPS terminal req.

$0.16

Spread vs growth

15.7%

10Y implied EPS CAGR

1.9%

fácil

EPS terminal req.

$0.26

Spread vs growth

8.1%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · available periodreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

7.6x → 7.0x

EPS bridge

0.20 → 0.22

Residual

-0.9%

EPS growth+10.0%
Multiple rerating-9.1%
Dividend+0.0%
Residual / FX / buybacks / cross-term-0.9%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.